BackImmunotech Laboratories Overview

Immunotech Laboratories Long Term Debt

Immunotech Laboratories's long-term debt is $1.6M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.65M

Peer trimmed avg / median

Loading

Immunotech Laboratories Long Term Debt History

Loading

Immunotech Laboratories vs. peers: Long Term Debt Comparison

Loading

Immunotech Laboratories Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Immunotech Laboratories (IMMB) FAQ

Immunotech Laboratories (IMMB) currently reports a long-term debt of $1.6M as of December 2016. Use the charts on this page to explore Immunotech Laboratories's long-term debt history and peer comparisons.

Immunotech Laboratories reported $1.6M in long-term debt as of December 2016. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $1.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immunotech Laboratories, and consider following IMMB for alerts when major investors trade the stock.

Immunotech Laboratories is classified in the Healthcare sector. On long-term debt, it currently shows $1.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMMB with unrelated industries.

Questions & Answers